Mixed Hormone Receptor (ER+/PR- Or ER-/PR+) Breast Cancer
By A Mystery Man Writer
Description
Detailed information on mixed hormone receptor (ER+/PR- or ER-/PR+) breast cancer prognosis, based on the latest scientific studies.
Cancers, Free Full-Text
Crosstalk between ER and HER family receptors. ER, estrogen receptor;
Mixed Hormone Receptor (ER+/PR- Or ER-/PR+) Breast Cancer Prognosis
Role of hormone receptors and HER2 as prospective molecular markers for breast cancer: An update - ScienceDirect
A novel oncogenic enhancer of estrogen receptor-positive breast cancer - ScienceDirect
Cancers, Free Full-Text
Estrogen receptor-negative/progesterone receptor-positive and her-2-negative breast cancer might no longer be classified as hormone receptor-positive breast cancer
The Clinical and Biological Significance of Estrogen Receptor-Low Positive Breast Cancer - Modern Pathology
ER and PR signaling nodes during mammary gland development, Breast Cancer Research
The challenges of modeling hormone receptor-positive breast cancer in mice in: Endocrine-Related Cancer Volume 25 Issue 5 (2018)
An overview on Estrogen receptors signaling and its ligands in breast cancer - ScienceDirect
Challenges in Treating Estrogen Receptor-Positive Breast Cancer
Combined quantitative measures of ER, PR, HER2, and KI67 provide more prognostic information than categorical combinations in luminal breast cancer
from
per adult (price varies by group size)